<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK3821" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK3821/" /><meta name="ncbi_pagename" content="VCAN-Related Vitreoretinopathy - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>VCAN-Related Vitreoretinopathy - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="VCAN-Related Vitreoretinopathy" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/01/07" /><meta name="citation_author" content="Barbara Kloeckener-Gruissem" /><meta name="citation_author" content="Christoph Amstutz" /><meta name="citation_pmid" content="20301747" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK3821/" /><meta name="citation_keywords" content="Wagner Vitreoretinal Degeneration (Wagner Synrdome)" /><meta name="citation_keywords" content="Erosive Vitreoretinopathy (ERVR)" /><meta name="citation_keywords" content="Versican core protein" /><meta name="citation_keywords" content="VCAN" /><meta name="citation_keywords" content="VCAN-Related Vitreoretinopathy" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="VCAN-Related Vitreoretinopathy" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Barbara Kloeckener-Gruissem" /><meta name="DC.Contributor" content="Christoph Amstutz" /><meta name="DC.Date" content="2016/01/07" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK3821/" /><meta name="description" content="VCAN-related vitreoretinopathy, which includes Wagner syndrome and erosive vitreoretinopathy (ERVR), is characterized by &quot;optically empty vitreous&quot; on slit-lamp examination and avascular vitreous strands and veils, mild or occasionally moderate to severe myopia, presenile cataract, night blindness of variable degree associated with progressive chorioretinal atrophy, retinal traction and retinal detachment in the advanced stages of disease, and reduced visual acuity. Optic nerve inversion as well as uveitis has also been described. Systemic abnormalities are not observed. The first signs usually become apparent during early adolescence, but onset can be as early as age two years." /><meta name="og:title" content="VCAN-Related Vitreoretinopathy" /><meta name="og:type" content="book" /><meta name="og:description" content="VCAN-related vitreoretinopathy, which includes Wagner syndrome and erosive vitreoretinopathy (ERVR), is characterized by &quot;optically empty vitreous&quot; on slit-lamp examination and avascular vitreous strands and veils, mild or occasionally moderate to severe myopia, presenile cataract, night blindness of variable degree associated with progressive chorioretinal atrophy, retinal traction and retinal detachment in the advanced stages of disease, and reduced visual acuity. Optic nerve inversion as well as uveitis has also been described. Systemic abnormalities are not observed. The first signs usually become apparent during early adolescence, but onset can be as early as age two years." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK3821/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/wagner/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK3821/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE89A5C7E04028D10000000006B202EB.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK3821_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK3821_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/usher2/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/vldlr-ch/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK3821_"><span class="title" itemprop="name"><i>VCAN</i>-Related Vitreoretinopathy</span></h1><p class="contrib-group"><span itemprop="author">Barbara Kloeckener-Gruissem</span>, PhD and <span itemprop="author">Christoph Amstutz</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK3821_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK3821_ai__"><div class="contrib half_rhythm"><span itemprop="author">Barbara Kloeckener-Gruissem</span>, PhD<div class="affiliation small">Institute of Medical Molecular Genetics<br />University of Zurich and ETH Zurich<br />Department of Biology<br />ETH Zurich<br />Zurich, Switzerland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="hc.hzu.negdem@renekceolk" class="oemail">hc.hzu.negdem@renekceolk</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Christoph Amstutz</span>, MD, PhD<div class="affiliation small">Luzerner Kantonsspital<br />Lucerne, Switzerland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="hc.skul@ztutsma.hpotsirhc" class="oemail">hc.skul@ztutsma.hpotsirhc</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 3, 2009</span>; Last Update: <span itemprop="dateModified">January 7, 2016</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="wagner.Summary" itemprop="description"><h2 id="_wagner_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>VCAN</i>-related vitreoretinopathy, which includes Wagner syndrome and erosive vitreoretinopathy (ERVR), is characterized by "optically empty vitreous" on slit-lamp examination and avascular vitreous strands and veils, mild or occasionally moderate to severe myopia, presenile cataract, night blindness of variable degree associated with progressive chorioretinal atrophy, retinal traction and retinal detachment in the advanced stages of disease, and reduced visual acuity. Optic nerve inversion as well as uveitis has also been described. Systemic abnormalities are not observed. The first signs usually become apparent during early adolescence, but onset can be as early as age two years.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>VCAN</i>-related vitreoretinopathy is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with characteristic ocular findings and a family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance. Identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>VCAN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> establishes the diagnosis if clinical features are inconclusive.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Refractive error is corrected by spectacles or contact lenses; visually disabling cataract is treated by cataract surgery, preferably by an experienced surgeon. Posterior capsule opacification is treated with YAG laser capsulotomy. Retinal breaks without retinal detachment are treated with laser retinopexy or cryocoagulation. Vitreoretinal surgery is indicated for retinal detachment, vitreoretinal traction involving the macula, or epiretinal membranes involving the macula.</p><p><i>Surveillance:</i> Annual ophthalmologic examination by a vitreoretinal specialist.</p><p><i>Evaluation of relatives at risk:</i> For the purpose of early diagnosis and treatment of ophthalmologic complications in at-risk relatives: <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the family; otherwise, ophthalmologic evaluation.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>VCAN</i>-related vitreoretinopathy is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Most individuals diagnosed with <i>VCAN</i>-related vitreoretinopathy have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Each child of an affected individual has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Prenatal testing is possible for families in which the pathogenic variant is known.</p></div></div><div id="wagner.GeneReview_Scope"><h2 id="_wagner_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="wagner.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK3821/table/wagner.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__wagner.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_wagner.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>VCAN-</i>Related Vitreoretinopathy: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_wagner.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Wagner vitreoretinal degeneration (Wagner syndrome)</div></li><li class="half_rhythm"><div>Erosive vitreoretinopathy (ERVR)</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#wagner.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="wagner.TF.c.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#wagner.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="wagner.Diagnosis"><h2 id="_wagner_Diagnosis_">Diagnosis</h2><div id="wagner.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>VCAN</i>-related vitreoretinopathy <b>should be suspected</b> in individuals with the following characteristic features:</p><ul><li class="half_rhythm"><div>"Optically empty vitreous" on slit-lamp examination and avascular vitreous strands and veils</div></li><li class="half_rhythm"><div>Mild or occasionally moderate to severe myopia</div></li><li class="half_rhythm"><div>Presenile cataract</div></li><li class="half_rhythm"><div>Night blindness of variable degree associated with progressive chorioretinal atrophy</div></li><li class="half_rhythm"><div>Retinal traction and detachment at advanced stages of the disease</div></li><li class="half_rhythm"><div>Reduced visual acuity resulting from the above manifestations</div></li><li class="half_rhythm"><div>Uveitis</div></li><li class="half_rhythm"><div>Absence of systemic abnormalities</div></li></ul></div><div id="wagner.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>VCAN</i>-related vitreoretinopathy <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the above clinical findings and a family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance. Not every clinical finding listed above is observed in every <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual. The hallmark, however, is the empty vitreous. Establishing the diagnosis may be more difficult in a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family). Identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>VCAN</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK3821/table/wagner.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figwagnerTmoleculargenetictestingused" rid-ob="figobwagnerTmoleculargenetictestingused">Table 1</a>) establishes the diagnosis if clinical features are inconclusive.</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> All <i>VCAN</i> pathogenic variants associated with Wagner syndrome and erosive vitreoretinopathy found to date have been in the splice acceptor or splice donor site of introns 7 and 8; <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of this DNA region is recommended as a first step. If targeted testing is not available, sequence analysis of <i>VCAN</i> should be done.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>VCAN</i> and other genes of interest (see <a href="#wagner.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note (1): The genes included and <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of multigene panels vary by laboratory and are likely to change over time. (2) The presence of characteristic connective tissue abnormalities in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> or relatives could prompt genetic testing for <a href="/books/n/gene/stickler/">Stickler syndrome</a> rather than or in addition to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>VCAN</i>.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="wagner.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>VCAN</i>-Related Vitreoretinopathy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK3821/table/wagner.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__wagner.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_wagner.T.molecular_genetic_testing_used_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_wagner.T.molecular_genetic_testing_used_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_wagner.T.molecular_genetic_testing_used_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_wagner.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>VCAN</i></td><td headers="hd_h_wagner.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_wagner.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">18/20 families with <i>VCAN</i>-related vitreoretinopathy&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_wagner.T.molecular_genetic_testing_used_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_wagner.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="wagner.TF.1.1"><p class="no_margin">See <a href="/books/NBK3821/#wagner.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="wagner.TF.1.2"><p class="no_margin">See <a href="#wagner.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="wagner.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="wagner.TF.1.4"><p class="no_margin">In 18 of 20 families with <i>VCAN</i>-related vitreoretinopathy, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the entire <i>VCAN</i> <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> and flanking introns identified pathogenic variants; in two families no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was found (see references in <a class="figpopup" href="/books/NBK3821/table/wagner.T.selected_vcan_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figwagnerTselectedvcanpathogenicvarian" rid-ob="figobwagnerTselectedvcanpathogenicvarian">Table 2</a>).</p></div></dd><dt>5. </dt><dd><div id="wagner.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="wagner.TF.1.6"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd></dl></div></div></div></div></div><div id="wagner.Clinical_Characteristics"><h2 id="_wagner_Clinical_Characteristics_">Clinical Characteristics</h2><div id="wagner.Clinical_Description"><h3>Clinical Description</h3><p><i>VCAN</i>-related vitreoretinopathy comprises the phenotypic continuum of Wagner vitreoretinal degeneration (Wagner syndrome) and erosive vitreoretinopathy (ERVR).</p><p><b>Vitreoretinal degeneration.</b> The hallmark of <i>VCAN</i>-related vitreoretinopathy is progressive degenerative changes of the vitreous (syneresis) and the vitreoretinal interface beginning at a young age. Syneresis can lead to massive liquefaction of the vitreous such that on slit-lamp examination the vitreous cavity appears optically empty ("empty vitreous") with pockets of liquefied vitreous that are usually lined by avascular strands and veils. Preretinal vitreous membranes that span the whole equator of the eye are characteristic. Ocular changes show considerable inter- and <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a>.</p><p>The first signs usually become apparent during early adolescence, but onset can be as early as age two years [<a class="bk_pop" href="#wagner.REF.miyamoto.2005.2726">Miyamoto et al 2005</a>].</p><p>No gender-specific difference in the occurrence or frequency of any particular ocular features has been observed.</p><p>The vitreous degeneration, which is assumed to be the primary pathology, leads to a number of secondary changes, including presenile cataract, degeneration and atrophy of the retina and the underlying retinal pigment epithelium (RPE) and choroid, and retinal detachment [<a class="bk_pop" href="#wagner.REF.wagner.1938.840">Wagner 1938</a>, <a class="bk_pop" href="#wagner.REF.jansen.1962.458">Jansen 1962</a>, <a class="bk_pop" href="#wagner.REF.graemiger.1995.1830">Graemiger et al 1995</a>, <a class="bk_pop" href="#wagner.REF.zech.1999.387">Zech et al 1999</a>, <a class="bk_pop" href="#wagner.REF.miyamoto.2005.2726">Miyamoto et al 2005</a>, <a class="bk_pop" href="#wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay et al 2006</a>, <a class="bk_pop" href="#wagner.REF.meredith.2007.655">Meredith et al 2007</a>].</p><div id="wagner.Common_Ocular_Features__60_of_Aff"><h4>Common Ocular Features (&#x02264;60% of Affected Individuals)</h4><p><b>Myopic refractive error</b> (nearsightedness) results from axial myopia (a developmental mismatch of the refractive power and length of the globe) and/or index myopia (a change in the refractive index of the progressively cataractous lens). Axial myopia is common, although severity varies. In the family reported by Wagner, most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> members had mild myopia and only a few had moderate to severe myopia. In contrast, in the Dutch family all members had high myopia with astigmatism [<a class="bk_pop" href="#wagner.REF.jansen.1962.458">Jansen 1962</a>].</p><p><b>Presenile cataract</b> (progressive loss of transparency of the ocular lens) is a common finding and a common cause of decline in visual acuity over time. The types of cataract vary. Small spherical opacities and posterior subcapsular cataract <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> 43% of eyes in the original family reported by Wagner [<a class="bk_pop" href="#wagner.REF.graemiger.1995.1830">Graemiger et al 1995</a>]. In the Dutch families, cataract types included moderate cortical cataract, anterior and posterior cortical cataract, and posterior subcapsular cataract [<a class="bk_pop" href="#wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay et al 2006</a>]. Nuclear cataract without any posterior subcapsular opacity was described in a British family [<a class="bk_pop" href="#wagner.REF.meredith.2007.655">Meredith et al 2007</a>].</p><p>In a Japanese family, approximately 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals underwent cataract surgery; the oldest was age 35 years [<a class="bk_pop" href="#wagner.REF.miyamoto.2005.2726">Miyamoto et al 2005</a>]. In a French family, cataract affected 55% of individuals [<a class="bk_pop" href="#wagner.REF.zech.1999.387">Zech et al 1999</a>]. Of note, even after cataract extraction and correction of the refractive error, visual acuity was not normal, typically ranging from 6/12 (20/40) to 6/24 (20/80).</p><p><b>Nonspecific reactive changes of the retinal pigment epithelium and overlying retina</b> (pigment condensation, vascular sheathing, pigmented lattice degeneration, and later chorioretinal atrophy in the retinal periphery) occur. Affected individuals may experience nyctalopia (night blindness) and visual field constriction that are not as severe as those seen in <a href="/books/n/gene/rp-overview/">retinitis pigmentosa</a>. Nyctalopia may or may not progress. In some individuals the chorioretinal atrophy is so severe that it resembles <a href="/books/n/gene/choroid/">choroideremia</a>. Diffuse retinal pigmentary changes and patchy chorioretinal atrophy are observed in some (but not all) family members <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> by Wagner syndrome [<a class="bk_pop" href="#wagner.REF.meredith.2007.655">Meredith et al 2007</a>, <a class="bk_pop" href="#wagner.REF.ronan.2009.1511">Ronan et al 2009</a>].</p><p>The full-field electroretinogram (ERG) becomes attenuated. Typically both the amplitudes of the a-waves (response of the photoreceptor layer) and the b-waves (response of the bipolar cell layer) are reduced. The rod and cone systems (as measured by the scotopic and photopic response, respectively) are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> to varying degrees but in a family-specific manner, as demonstrated by the Swiss family originally reported by Wagner, the Japanese family, and the British family [<a class="bk_pop" href="#wagner.REF.graemiger.1995.1830">Graemiger et al 1995</a>, <a class="bk_pop" href="#wagner.REF.miyamoto.2005.2726">Miyamoto et al 2005</a>, <a class="bk_pop" href="#wagner.REF.meredith.2007.655">Meredith et al 2007</a>].</p><p><b>Abnormal retinal vessels or poor vascularization of the peripheral retina</b> were found in approximately 50% of individuals from the family reported by Wagner [<a class="bk_pop" href="#wagner.REF.graemiger.1995.1830">Graemiger et al 1995</a>], but only in a few individuals of the Dutch families [<a class="bk_pop" href="#wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay et al 2006</a>].</p><p><b>Retinal detachment</b> was initially found to be associated with increasing age; however, a later report indicated that detachments can occur earlier (average age 9.5 years) [<a class="bk_pop" href="#wagner.REF.ronan.2009.1511">Ronan et al 2009</a>]. Caused by shrinkage of the preretinal membranes and the vitreous strands and veils, retinal detachment is either tractional or rhegmatogenous.</p><ul><li class="half_rhythm"><div>Tractional retinal detachment is caused by tangential shortening of the adhering membranes. The detached retina is rigid; successful surgical repair requires meticulous removal of the membranes and vitreoretinal adhesions and, most often, extensive retinotomies to relieve the traction. Tractional retinal detachment is not a particularly common feature of Wagner syndrome.</div></li><li class="half_rhythm"><div>Rhegmatogenous retinal detachment is caused by retinal breaks associated with the preretinal membranes. Liquefied vitreous fluid enters the potential subretinal space through one or more retinal tears caused by shrinking membranes. The retinal detachment is typically bullous; surgical repair primarily relies on closure of all retinal breaks. Of note, in a considerable number of young individuals rhegmatogenous retinal detachment associated with hereditary vitreoretinal degeneration presents with only minor changes of the vitreous. Consequently, large retinal tears in young persons should raise the suspicion of a hereditary disease, and should prompt examination of other family members and eventually molecular genetic analysis.</div></li></ul><p>In the original publication by Wagner the incidence of retinal detachment at age 20 years was one in four, whereas in the Dutch pedigrees published by Jansen bilateral retinal detachment was a frequent finding at a young age. Of note, follow-up publications of the original Wagner <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a> reported an incidence of retinal detachment of greater than one in two. Of the few retinal detachments described in the Swiss family reported originally by Wagner and in the Dutch families reported by Jansen, some were peripheral tractional [<a class="bk_pop" href="#wagner.REF.graemiger.1995.1830">Graemiger et al 1995</a>, <a class="bk_pop" href="#wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay et al 2006</a>]. Further tractional effects were observed as situs inversus [<a class="bk_pop" href="#wagner.REF.wagner.1938.840">Wagner 1938</a>]. Recently, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals were described with inversion of the papilla as a possible consequence of tractional forces [<a class="bk_pop" href="#wagner.REF.ronan.2009.1511">Ronan et al 2009</a>].</p><p>In the Japanese family reported by <a class="bk_pop" href="#wagner.REF.miyamoto.2005.2726">Miyamoto et al [2005]</a>, most of the retinal detachments were rhegmatogenous. No retinal detachments were observed in the only two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported in a British family [<a class="bk_pop" href="#wagner.REF.meredith.2007.655">Meredith et al 2007</a>].</p></div><div id="wagner.Occasional_Ocular_Features"><h4>Occasional Ocular Features</h4><p>The following features have been reported rarely. Some may not be part of <i>VCAN</i>-related vitreoretinopathy but rather occur coincidentally.</p><p><b>Spherophakia</b>, a spherical deformation of the ocular lens, has been observed sporadically in persons with <i>VCAN</i>-related vitreoretinopathy [<a class="bk_pop" href="#wagner.REF.graemiger.1995.1830">Graemiger et al 1995</a>].</p><p><b>Cataract</b> can induce a change of the refractive index of the lens nucleus, further attenuating the myopic refractive error (index myopia).</p><p><b>Posterior vitreous detachment</b> (PVD), detachment of the posterior vitreous membrane from the retinal surface, is caused by shrinkage of the vitreous body and the pathologic vitreoretinal interface. In contrast to the usual age-related PVD, the PVD in <i>VCAN</i>-related vitreoretinopathy initially affects the peripheral rather than the central posterior vitreous. None of the individuals from the original family described by Wagner or the French family showed PVD [<a class="bk_pop" href="#wagner.REF.graemiger.1995.1830">Graemiger et al 1995</a>, <a class="bk_pop" href="#wagner.REF.zech.1999.387">Zech et al 1999</a>].</p><p><b>Ectopic fovea</b>, manifesting as an increased angle kappa (the angle between the visual axis and the pupillary axis), has occasionally been reported [<a class="bk_pop" href="#wagner.REF.graemiger.1995.1830">Graemiger et al 1995</a>, <a class="bk_pop" href="#wagner.REF.miyamoto.2005.2726">Miyamoto et al 2005</a>, <a class="bk_pop" href="#wagner.REF.meredith.2007.655">Meredith et al 2007</a>].</p><p><b>Phthisis bulbi</b> (painful shrinking of the ocular globe as a result of loss of intraocular pressure) can occur and may require enucleation of the eye. Retinal detachment that has not been repaired successfully and retinal detachment associated with proliferative retinal vitreoretinopathy (PVR) are risk factors for phthisis bulbi. The decrease in intraocular pressure is caused by decreased aqueous production by the ciliary body epithelium, which becomes compromised by the pathologic vitreoretinal membranes because of the primary vitreal changes, the PVR, or both.</p><p><b>Synchysis scintillans</b> (bilateral accumulation of cholesterol crystals in the vitreous, which may or may not be associated with recurrent vitreous hemorrhage), may or may not occur with increased frequency in <i>VCAN</i>-related vitreoretinopathy, as it was only observed in a few older <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#wagner.REF.graemiger.1995.1830">Graemiger et al 1995</a>, <a class="bk_pop" href="#wagner.REF.zech.1999.387">Zech et al 1999</a>].</p><p><b>Optic atrophy</b> was found in only a few of the older individuals from the original Wagner family. These individuals had advanced chorioretinal atrophy, suggesting that optic atrophy is secondary to the massive loss in retinal ganglion cells [<a class="bk_pop" href="#wagner.REF.graemiger.1995.1830">Graemiger et al 1995</a>].</p><p><b>Glaucoma</b> may be an occasional feature of Wagner syndrome, or a sequela of the disease such as aphakia glaucoma or rubeotic glaucoma. In the original <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a>, ten individuals out of the sixty family members exhibited a dysgenetic chamber angle [<a class="bk_pop" href="#wagner.REF.graemiger.1995.1830">Graemiger et al 1995</a>]; one individual had <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> glaucoma. Three individuals with congenital glaucoma were reported by <a class="bk_pop" href="#wagner.REF.jewsbury.2014.291">Jewsbury et al [2014]</a>.</p><p><b>Exudative vitreoretinopathy</b> with vascular abnormalities has been reported in one French family [<a class="bk_pop" href="#wagner.REF.br_zin.2011.1669">Br&#x000e9;zin et al 2011</a>]; in fact, <a href="/books/n/gene/fevr/">familial exudative vitreoretinopathy</a> (FEVR) was the initial diagnosis suspected in this family.</p><p><b>Uveitis</b> is a rare clinical feature of <i>VCAN</i>-related vitreoretinopathy that has come to attention only recently. Uveitis was reported in a French [<a class="bk_pop" href="#wagner.REF.br_zin.2011.1669">Br&#x000e9;zin et al 2011</a>] and a British [<a class="bk_pop" href="#wagner.REF.meredith.2007.655">Meredith et al 2007</a>] family as spontaneous anterior uveitis, and otherwise unexplained severe and prolonged intraocular inflammation after uneventful cataract surgery, respectively [<a class="bk_pop" href="#wagner.REF.rothschild.2011.1555">Rothschild et al 2011</a>, <a class="bk_pop" href="#wagner.REF.rothschild.2013b.2040">Rothschild et al 2013b</a>]. Given versican's role in inflammation and cancer that was increasingly elucidated during the last decade, the occurrence of uveitis in individuals with <i>VCAN</i>-related vitreoretinopathy is likely related to the causative genetic defect [<a class="bk_pop" href="#wagner.REF.du.2013.701">Du et al 2013</a>, <a class="bk_pop" href="#wagner.REF.wight.2014.152">Wight et al 2014</a>].</p><p><b>Systemic findings.</b> No systemic abnormalities associated with <i>VCAN</i>-related vitreoretinopathy have been reported to date, and consequently <i>VCAN</i>-related vitreoretinopathy is considered an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> vitreoretinal degeneration.</p></div></div><div id="wagner.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Because of the highly variable frequency of findings and the low number of pathogenic variants identified to date, no definite <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been established.</p></div><div id="wagner.Penetrance"><h3>Penetrance</h3><p>Penetrance appears to be complete. Within families reported to date, no unaffected individuals had a <i>VCAN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="wagner.Nomenclature"><h3>Nomenclature</h3><p>Some authors have referred to <a href="/books/n/gene/stickler/">Stickler syndrome</a> associated with pathogenic variants in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 of <i>COL2A1</i> as Wagner syndrome type II. The <i>VCAN</i>-related <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> has been referred to as vitreoretinochoroidopathy (VRCP) Wagner syndrome type I [<a class="bk_pop" href="#wagner.REF.gupta.2002.203">Gupta et al 2002</a>] or hyaloideoretinal degeneration of Wagner.</p></div><div id="wagner.Prevalence"><h3>Prevalence</h3><p>Wagner syndrome is a very rare disorder. After the first Swiss <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a> reported by <a class="bk_pop" href="#wagner.REF.wagner.1938.840">Wagner [1938]</a>, several additional families (some of them very large) have been reported. Including families with ERVR, not more than 50 families or <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases of <i>VCAN</i>-related vitreoretinopathy have been reported.</p><p>Wagner syndrome has been reported in families of various ethnic backgrounds including northern European, Japanese, and Chinese.</p></div></div><div id="wagner.Genetically_Related_Allelic_Disor"><h2 id="_wagner_Genetically_Related_Allelic_Disor_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>VCAN</i>.</p></div><div id="wagner.Differential_Diagnosis"><h2 id="_wagner_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Syndromes with overlapping features.</b> A review by <a class="bk_pop" href="#wagner.REF.edwards.2008.460">Edwards [2008]</a> summarizes the clinical features of inherited vitreoretinopathies and points out the importance of consulting an expert ophthalmologist in diagnostic assessment of the disease.</p><div id="wagner.Autosomal_Dominant_Vitreoretinopa"><h3>Autosomal Dominant Vitreoretinopathies</h3><p><b>Snowflake vitreoretinal degeneration (SVD)</b> (OMIM <a href="http://omim.org/entry/193230" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">193230</a>). SVD is caused by pathogenic variants in <i>KCNJ13</i>.</p><ul><li class="half_rhythm"><div>Both SVD and <i>VCAN</i>-related vitreoretinopathy exhibit vitreous abnormalities including fibrillar condensation, gel liquefaction, and marked thickening of the cortical vitreous.</div></li><li class="half_rhythm"><div>In SVD, however, membranous degeneration of the vitreous with avascular strands and veils is not observed. Retinal defects start in the superficial retinal layers, whereas in <i>VCAN</i>-related vitreoretinopathy they start in the deep retinal layers and choroid; retinal detachment is uncommon; and the retinal crystalline snowflake-like deposits that give the disease its name are common.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/stickler/">Stickler syndrome</a>, or hereditary arthroophthalmopathy, is a connective tissue disorder that can include ocular findings of myopia, cataract, and retinal detachment; hearing loss that is both conductive and sensorineural; midfacial underdevelopment and cleft palate (either alone or as part of the Robin sequence); and mild spondyloepiphyseal dysplasia and/or precocious arthritis. Variable phenotypic expression of Stickler syndrome occurs both within and among families; <a class="def" href="/books/n/gene/glossary/def-item/interfamilial-variability/">interfamilial variability</a> is in part explained by <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and <a class="def" href="/books/n/gene/glossary/def-item/allelic-heterogeneity/">allelic heterogeneity</a>. Stickler syndrome caused by mutation of <i>COL2A1</i>, <i>COL11A1</i>, or <i>COL11A2</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</div></li><li class="half_rhythm"><div>Retinal detachment is much more common in Stickler syndrome (50%) than in <i>VCAN</i>-related vitreoretinopathy (15%).</div></li><li class="half_rhythm"><div>Abnormal dark adaptation associated with alterations in the electroretinogram (ERG) that is common in <i>VCAN</i>-related vitreoretinopathy has not been described in Stickler syndrome.</div></li><li class="half_rhythm"><div>Type 1 Stickler syndrome (in which individuals have the membranous type of vitreous abnormality) is caused by pathogenic variants in <i>COL2A1</i> encoding collagen alpha-1(II) chain. Certain pathogenic variants in <i>COL2A1</i> cause a predominantly ocular or nonsyndromic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> which can be readily distinguished from Wagner syndrome by the specific vitreous anomaly associated with type 1 Stickler syndrome. However, some authors have referred to this form of Stickler syndrome as Wagner syndrome type II [<a class="bk_pop" href="#wagner.REF.gupta.2002.203">Gupta et al 2002</a>].</div></li></ul><p><b>Autosomal dominant vitreoretinochoroidopathy (ADVIRC)</b> (OMIM <a href="http://omim.org/entry/193220" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">193220</a>). Pathogenic variants in <i>BEST1</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding bestrophin-1, are causative. Only a few families with vitreoretinochoroidopathy (VRCP) have been described. High myopia and retinal detachment do not appear to be part of VRCP [<a class="bk_pop" href="#wagner.REF.oh.2006.940">Oh &#x00026; Vallar 2006</a>]. Affected individuals show the following findings that seem to progress more slowly than those of <i>VCAN</i>-related vitreoretinopathy:</p><ul><li class="half_rhythm"><div>Fibrillar condensation of the vitreous, but not optically empty vitreous</div></li><li class="half_rhythm"><div>Chorioretinal hyperpigmentation with peripheral pigmentary clumping</div></li><li class="half_rhythm"><div>Macular atrophy</div></li><li class="half_rhythm"><div>Breakdown of the blood retinal barrier (observed in one family)</div></li><li class="half_rhythm"><div>Normal full-field (Ganzfeld) ERG but altered multifocal ERG pattern</div></li><li class="half_rhythm"><div>Cataract</div></li></ul><p><b>Autosomal dominant neovascular inflammatory vitreoretinopathy (ADNIV)</b> (OMIM <a href="http://omim.org/entry/193235" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">193235</a>)<b>.</b> Pathogenic variants in <i>CAPN5</i> are causative [<a class="bk_pop" href="#wagner.REF.mahajan.2012.e1003001">Mahajan et al 2012</a>]. <a class="bk_pop" href="#wagner.REF.bennett.1990.1125">Bennett et al [1990]</a> reported a six-generation family with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> vitreoretinopathy in which the prevailing clinical features were severe anterior and posterior segment inflammation, neovascular proliferations and related complications (in particular tractional retinal detachment and neovascular glaucoma), and a selective loss of the b-wave amplitude on the ERG early in the disease.</p></div><div id="wagner.Autosomal_Recessive_Vitreoretinop"><h3>Autosomal Recessive Vitreoretinopathies</h3><p><b>Goldmann-Favre syndrome (included in enhanced S-cone syndrome)</b> (OMIM <a href="http://omim.org/entry/268100" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">268100</a>). Pathogenic variants in <i>NR2E3</i> (photoreceptor-specific nuclear receptor) have been identified in Goldmann-Favre syndrome, enhanced S-cone syndrome (ESCS), and clumped pigmentary retinal degeneration [<a class="bk_pop" href="#wagner.REF.haider.2000.127">Haider et al 2000</a>]. These clinical entities are usually associated with night blindness and visual field constriction. Electroretinography characteristically reveals a severe reduction in rod function and a relatively enhanced function of the short-wavelength-sensitive cones.</p><ul><li class="half_rhythm"><div>The classic Goldmann-Favre <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> includes progressive vitreous changes (vitreous liquefaction and fibrillar strands and veils); night blindness and severe reduction in the ERG in early childhood; chorioretinal atrophy and pigmentary retinal degeneration later in the disease course resulting in marked visual field loss; retinoschisis in the periphery, macula, or both; presenile cataract; and a hyperopic rather than myopic refractive error.</div></li><li class="half_rhythm"><div>Although ESCS lacks the marked vitreous changes typical of the Goldmann-Favre <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, vitreous cells are a very common feature, and more prominent vitreous changes including vitreous opacities, haze, and veils can occur. Peripheral retinoschisis has been observed in ESCS, and foveal schisis, eventually associated with cystoid changes, may even be a common feature. The fundus appearance varies, and features are overlapping with clumped pigmentary retinal degeneration, in which the retinal pigmentary changes are the most prominent feature of the phenotype [<a class="bk_pop" href="#wagner.REF.audo.2008.2082">Audo et al 2008</a>].</div></li></ul><p><b>Knobloch syndrome</b> (OMIM <a href="http://omim.org/entry/267750" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">267750</a>). Knobloch syndrome is a <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> vitreoretinopathy in which ocular changes similar to those of <i>VCAN</i>-related vitreoretinopathy are associated with occipital encephalocele. Pathogenic variants in <i>COL18A1</i> (encoding collagen, type XVIII, alpha 1) are causative [<a class="bk_pop" href="#wagner.REF.menzel.2004.77">Menzel et al 2004</a>, <a class="bk_pop" href="#wagner.REF.keren.2007.1514">Keren et al 2007</a>].</p></div></div><div id="wagner.Management"><h2 id="_wagner_Management_">Management</h2><div id="wagner.Evaluations_Following_Initial_Dia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>VCAN</i>-related vitreoretinopathy, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Baseline ophthalmologic examination including best corrected visual acuity, assessment of intraocular pressure, slit-lamp examination of the anterior segment, and biomicroscopy and indirect ophthalmoscopy of the posterior segment</div></li><li class="half_rhythm"><div>Visual field examination</div></li><li class="half_rhythm"><div>Photographic fundus documentation</div></li><li class="half_rhythm"><div>Optical coherence tomography (OCT), if available. While not mandatory, OCT scan is useful to assess the vitreoretinal interface, quantify atrophic changes of the central retina, and evaluate for cystoid macular edema.</div></li><li class="half_rhythm"><div>Electroretinogram</div></li><li class="half_rhythm"><div>Orthoptic assessment</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="wagner.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Refractive error</b> is corrected by spectacles or contact lenses.</p><p><b>Visually disabling cataract</b> is treated by cataract surgery. Phacoemulsification and implantation of an intraocular lens in the capsular bag has become the widely adopted standard procedure; however, as emphasized by Edwards, cataract surgery in individuals with vitreoretinopathy and possibly preceding vitrectomy can be difficult and should be performed by an experienced surgeon [<a class="bk_pop" href="#wagner.REF.miyamoto.2005.2726">Miyamoto et al 2005</a>, <a class="bk_pop" href="#wagner.REF.edwards.2008.460">Edwards 2008</a>].</p><p><b>Posterior capsule opacification</b> after cataract surgery is treated with YAG laser capsulotomy.</p><p><b>Retinal breaks</b> are treated with laser retinopexy or cryocoagulation if no retinal detachment is present.</p><p><b>Vitreoretinal surgery</b> is indicated for retinal detachment, vitreoretinal traction involving the macula, or epiretinal membranes involving the macula.</p></div><div id="wagner.Surveillance"><h3>Surveillance</h3><p>Annual ophthalmologic examination by a vitreoretinal specialist is indicated.</p></div><div id="wagner.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to reduce morbidity by early diagnosis and treatment of ophthalmologic complications.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known.</div></li><li class="half_rhythm"><div>Ophthalmologic exam if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is not known</div></li></ul><p>See <a href="#wagner.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="wagner.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://www.ClinicalTrials.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="wagner.Genetic_Counseling"><h2 id="_wagner_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="wagner.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>VCAN</i>-related vitreoretinopathy is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="wagner.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with <i>VCAN</i>-related vitreoretinopathy have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <i>VCAN</i>-related vitreoretinopathy may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by a <i>de novo</i> pathogenic variant is not known.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include ophthalmologic evaluation and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of both parents.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent (although no instances of germline mosaicism have been reported, it remains a possibility).</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with <i>VCAN</i>-related vitreoretinopathy may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations (e.g., ophthalmologic exam and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>) have been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li><li class="half_rhythm"><div>Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has <i>VCAN</i>-related vitreoretinopathy, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>If the <i>VCAN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <i>VCAN</i>-related vitreoretinopathy has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the status of the proband's parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members may be at risk.</p></div><div id="wagner.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#wagner.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="wagner.Prenatal_Testing_and_Preimplantat"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>VCAN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for <i>VCAN</i>-related vitreoretinopathy are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="wagner.Resources"><h2 id="_wagner_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Eye Institute</b></div><div>31 Center Drive</div><div>MSC 2510</div><div>Bethesda MD 20892-2510</div><div><b>Phone:</b> 301-496-5248</div><div><b>Email:</b> 2020@nei.nih.gov</div><div><a href="https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/low-vision" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Low Vision</a></div></li><li class="half_rhythm"><div><b>National Eye Institute</b></div><div>31 Center Drive</div><div>MSC 2510</div><div>Bethesda MD 20892-2510</div><div><a href="https://www.nei.nih.gov/health/cataract/cataract_facts" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Facts About Cataract</a></div></li><li class="half_rhythm"><div><b>National Eye Institute</b></div><div>31 Center Drive</div><div>MSC 2510</div><div>Bethesda MD 20892-2510</div><div><b>Phone:</b> 301-496-5248</div><div><b>Email:</b> 2020@nei.nih.gov</div><div><a href="https://nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/retinal-detachment" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Retinal Detachment</a></div></li><li class="half_rhythm"><div><b>Prevent Blindness America</b></div><div>211 West Wacker Drive</div><div>Suite 1700</div><div>Chicago IL 60606</div><div><b>Phone:</b> 800-331-2020 (toll-free)</div><div><b>Email:</b> info@preventblindness.org</div><div><a href="http://www.preventblindness.org/cataract" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Cataract</a></div></li></ul></div><div id="wagner.Molecular_Genetics"><h2 id="_wagner_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="wagner.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>VCAN-Related Vitreoretinopathy: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK3821/table/wagner.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__wagner.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_wagner.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_wagner.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_wagner.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_wagner.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_wagner.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_wagner.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_wagner.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1462" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>VCAN</i></a></td><td headers="hd_b_wagner.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1462" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">5q14<wbr style="display:inline-block"></wbr>​.2-q14.3</a></td><td headers="hd_b_wagner.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P13611" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Versican core protein</a></td><td headers="hd_b_wagner.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://proteomics.bio21.unimelb.edu.au/lovd/genes/VCAN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">VCAN-LOVD</a></td><td headers="hd_b_wagner.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=VCAN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">VCAN</a></td><td headers="hd_b_wagner.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=VCAN[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">VCAN</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="wagner.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="wagner.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for VCAN-Related Vitreoretinopathy (<a href="/omim/118661,143200" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK3821/table/wagner.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__wagner.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/118661" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">118661</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">VERSICAN; VCAN</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/143200" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">143200</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">WAGNER VITREORETINOPATHY; WGVRP</td></tr></tbody></table></div></div><div id="wagner.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>Since <i>VCAN</i> is expressed in many human tissues, pathogenic variants in <i>VCAN</i> could be expected to interfere with functions in tissues and organs other than the eye; the cardiovascular system in particular would seem a likely candidate, as versican, the protein product of <i>VCAN</i>, is a component of the extracellular matrix of the blood vessels [<a class="bk_pop" href="#wagner.REF.yao.1994.213">Yao et al 1994</a>, <a class="bk_pop" href="#wagner.REF.lemire.1999.1630">Lemire et al 1999</a>]. A possible explanation for the absence of consequences of <i>VCAN</i> pathogenic variants in nonocular tissues is that <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of the <i>VCAN</i> transcripts may be tissue specific.</p><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> region (109,399 nucleotides) of <i>VCAN</i> includes 15 exons (<a href="/nuccore/NM_004385.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004385.4</a>, splice variant V0). The two largest exons, 7 (2961 nucleotides) and 8 (5262 nucleotides), are subject to alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a>, yielding four naturally occurring splice variants (named V0, 1, 2, and 3; see <a class="figpopup" href="/books/NBK3821/figure/wagner.F1/?report=objectonly" target="object" rid-figpopup="figwagnerF1" rid-ob="figobwagnerF1">Figure 1</a>) that exhibit a tissue-specific expression pattern. The respective <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>-<a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> boundaries show the consensus sequences for splice acceptor and splice donor sites. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, splice variants, and protein information, see <a href="/books/NBK3821/#wagner.molgen.TA">Table A</a>, <b>Gene</b>.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figwagnerF1" co-legend-rid="figlgndwagnerF1"><a href="/books/NBK3821/figure/wagner.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figwagnerF1" rid-ob="figobwagnerF1"><img class="small-thumb" src="/books/NBK3821/bin/wagner-Image001.gif" src-large="/books/NBK3821/bin/wagner-Image001.jpg" alt="Figure 1. . Vitreoretinopathy-associated pathogenic variants in VCAN and their effects on naturally occurring splice variants and protein isoforms." /></a><div class="icnblk_cntnt" id="figlgndwagnerF1"><h4 id="wagner.F1"><a href="/books/NBK3821/figure/wagner.F1/?report=objectonly" target="object" rid-ob="figobwagnerF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Vitreoretinopathy-associated pathogenic variants in <i>VCAN</i> and their effects on naturally occurring splice variants and protein isoforms. Under normal conditions, differential splicing leads to four transcript variants and protein isoforms V0, V1, V2, or <a href="/books/NBK3821/figure/wagner.F1/?report=objectonly" target="object" rid-ob="figobwagnerF1">(more...)</a></p></div></div><p><b>Pathogenic variants.</b> Eleven different single nucleotide variants, all located in conserved splice consensus sites of introns 7 and 8, were identified in 17 families with vitreoretinopathy. In some cases, identical pathogenic variants have been found in different, unrelated families (<a class="figpopup" href="/books/NBK3821/table/wagner.T.selected_vcan_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figwagnerTselectedvcanpathogenicvarian" rid-ob="figobwagnerTselectedvcanpathogenicvarian">Table 2</a>). In several individuals, it was shown that the pathogenic variants can lead to aberrant splice products and/or to quantitative changes of the naturally occurring splice variants lacking <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 8. No pathogenic exon variants have been found.</p><div id="wagner.T.selected_vcan_pathogenic_varian" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Selected <i>VCAN</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK3821/table/wagner.T.selected_vcan_pathogenic_varian/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__wagner.T.selected_vcan_pathogenic_varian_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Intron<br />Location</th><th id="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"># of Families w/Pathogenic Variant</th><th id="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference</th><th id="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.9265+1G&#x0003e;A</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_2" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">Intron 8 splice donor site</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wagner.REF.rothschild.2013a.805">Rothschild et al [2013a]</a></td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_5" rowspan="11" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_004385.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004385<wbr style="display:inline-block"></wbr>​.4</a>
<a href="/protein/NP_004376.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_004376<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.9265+1G&#x0003e;T</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wagner.REF.kloeckenergruissem.2006.350">Kloeckener-Gruissem et al [2006]</a>, <a class="bk_pop" href="#wagner.REF.meredith.2007.655">Meredith et al [2007]</a>, <a class="bk_pop" href="#wagner.REF.ronan.2009.1511">Ronan et al [2009]</a></td></tr><tr><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.9265+2T&#x0003e;A</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wagner.REF.kloeckenergruissem.2013.352">Kloeckener-Gruissem et al [2013]</a></td></tr><tr><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4004-1G&#x0003e;A</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_2" rowspan="8" colspan="1" style="text-align:left;vertical-align:middle;">IVS 7 splice acceptor site</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay et al [2006]</a></td></tr><tr><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4004-1G&#x0003e;C</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wagner.REF.kloeckenergruissem.2013.352">Kloeckener-Gruissem et al [2013]</a></td></tr><tr><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4004-1G&#x0003e;T</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wagner.REF.chen.2013.2186">Chen et al [2013]</a></td></tr><tr><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4004-2A&#x0003e;G</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wagner.REF.miyamoto.2005.2726">Miyamoto et al [2005]</a>, <a class="bk_pop" href="#wagner.REF.br_zin.2011.1669">Br&#x000e9;zin et al [2011]</a></td></tr><tr><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4004-2A&#x0003e;T</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wagner.REF.br_zin.2011.1669">Br&#x000e9;zin et al [2011]</a></td></tr><tr><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4004-5T&#x0003e;C</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">4</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay et al [2006]</a></td></tr><tr><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4004-5T&#x0003e;A</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay et al [2006]</a></td></tr><tr><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4004-6T&#x0003e;A</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#wagner.REF.rothschild.2013b.2040">Rothschild et al [2013b]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The extracellular matrix proteoglycan (chondroitin sulfate proteoglycan type 2), also named versican core protein, is found in many different tissues in the human body, including the eye [<a class="bk_pop" href="#wagner.REF.white.2000.130">White &#x00026; Bruzzone 2000</a>]. Four naturally occurring protein <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> accumulate tissue-specifically. They are products of alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of exons 7 and 8 (see <a class="figpopup" href="/books/NBK3821/figure/wagner.F1/?report=objectonly" target="object" rid-figpopup="figwagnerF1" rid-ob="figobwagnerF1">Figure 1</a>). A central <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the protein, encoded by both exons 7 and 8, carries glycosaminoglycan (GAG) residue modifications, which may be involved in preventing collagen fibrils from adhering, thus ensuring the gel-like properties of the vitreous content. Versican appears to have a central role in the outflow resistance through the trabecular meshwork, and splicing variant patterns in the trabecular meshwork extracellular matrix are altered in glaucoma [<a class="bk_pop" href="#wagner.REF.keller.2007.1164">Keller et al 2007</a>, <a class="bk_pop" href="#wagner.REF.keller.2011.5049">Keller et al 2011</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants in splice consensus sites result in skipping of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 8 and in the production of aberrant splice products [<a class="bk_pop" href="#wagner.REF.miyamoto.2005.2726">Miyamoto et al 2005</a>, <a class="bk_pop" href="#wagner.REF.kloeckenergruissem.2006.350">Kloeckener-Gruissem et al 2006</a>, <a class="bk_pop" href="#wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay et al 2006</a>]. One consequence is increased accumulation of splice variant V2 (no exon 8; <a href="/protein/NP_001157570.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001157570.1</a>) and V3 (no exon 7 and 8; <a href="/protein/NP_001119808.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001119808.1</a>) [<a class="bk_pop" href="#wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay et al 2006</a>] and most likely their respective protein <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>. This may result in severe reduction of GAG modification, which will render the physical properties of the vitreous, leading to a process of premature liquefaction.</p></div></div><div id="wagner.References"><h2 id="_wagner_References_">References</h2><div id="wagner.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.audo.2008.2082">Audo I, Michaelides M, Robson AG, Hawlina M, Vaclavik V, Sandbach JM, Neveu MM, Hogg CR, Hunt DM, Moore AT, Bird AC, Webster AR, Holder GE. Phenotypic variation in enhanced S-cone syndrome. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2008;<span class="ref-vol">49</span>:2082–93.</span> [<a href="/pubmed/18436841" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18436841</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.bennett.1990.1125">Bennett SR, Folk JC, Kimura AE, Russell SR, Stone EM, Raphtis EM. Autosomal dominant neovascular inflammatory vitreoretinopathy. <span><span class="ref-journal">Ophthalmology. </span>1990;<span class="ref-vol">97</span>:1125–35.</span> [<a href="/pubmed/2234842" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2234842</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.br_zin.2011.1669">Br&#x000e9;zin AP, Nedelec B, Barjol A, Rothschild PR, Delpech M, Valleix S. A new VCAN/versican splice acceptor site mutation in a French Wagner family associated with vascular and inflammatory ocular features. <span><span class="ref-journal">Mol Vis. </span>2011;<span class="ref-vol">17</span>:1669–78.</span> [<a href="/pmc/articles/PMC3130719/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3130719</span></a>] [<a href="/pubmed/21738396" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21738396</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.chen.2013.2186">Chen X, Zhao K, Sheng X, Li Y, Gao X, Zhang X, Kang X, Pan X, Liu Y, Jiang C, Shi H, Chen X, Rong W, Chen LJ, Lai TY, Liu Y, Wang X, Yuan S, Liu Q, Vollrath D, Pang CP, Zhao C. Targeted sequencing of 179 genes associated with hereditary retinal dystrophies and 10 candidate genes identifies novel and known mutations in patients with various retinal diseases. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2013;2013;<span class="ref-vol">54</span>:2186–97.</span> [<a href="/pubmed/23462753" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23462753</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.du.2013.701">Du WW, Yang W, Yee AJ. Roles of versican in cancer biology--tumorigenesis, progression and metastasis. <span><span class="ref-journal">Histol Histopathol. </span>2013;<span class="ref-vol">28</span>:701–13.</span> [<a href="/pubmed/23519970" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23519970</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.edwards.2008.460">Edwards AO. Clinical features of the congenital vitreoretinopathies. <span><span class="ref-journal">Pediatr Dermatol. </span>2008;<span class="ref-vol">25</span>:460–1.</span> [<a href="/pubmed/18789088" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18789088</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.graemiger.1995.1830">Graemiger RA, Niemeyer G, Schneeberger SA, Messmer EP. Wagner vitreoretinal degeneration. Follow-up of the original pedigree. <span><span class="ref-journal">Ophthalmology. </span>1995;<span class="ref-vol">102</span>:1830–9.</span> [<a href="/pubmed/9098284" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9098284</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.gupta.2002.203">Gupta SK, Leonard BC, Damji KF, Bulman DE. A frame shift mutation in a tissue-specific alternatively spliced exon of collagen 2A1 in Wagner's vitreoretinal degeneration. <span><span class="ref-journal">Am J Ophthalmol. </span>2002;<span class="ref-vol">133</span>:203–10.</span> [<a href="/pubmed/11812423" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11812423</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.haider.2000.127">Haider NB, Jacobson SG, Cideciyan AV, Swiderski R, Streb LM, Searby C, Beck G, Hockey R, Hanna DB, Gorman S, Duhl D, Carmi R, Bennett J, Weleber RG, Fishman GA, Wright AF, Stone EM, Sheffield VC. Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate. <span><span class="ref-journal">Nat Genet. </span>2000;<span class="ref-vol">24</span>:127–31.</span> [<a href="/pubmed/10655056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10655056</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.jansen.1962.458">Jansen LM. Degeneratio hyaloideo-retinalis herditaria. <span><span class="ref-journal">Ophthalmologica. </span>1962;<span class="ref-vol">144</span>:458–64.</span> [<a href="/pubmed/14041873" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14041873</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.jewsbury.2014.291">Jewsbury H, Fry AE, Watts P, Nas V, Morgan J. Congenital glaucoma in Wagner syndrome. <span><span class="ref-journal">J AAPOS. </span>2014;<span class="ref-vol">18</span>:291–3.</span> [<a href="/pubmed/24767812" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24767812</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.keller.2007.1164">Keller KE, Kelley MJ, Acott TS. Extracellular matrix gene alternative splicing by trabecular meshwork cells in response to mechanical stretching. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2007;<span class="ref-vol">48</span>:1164–72.</span> [<a href="/pubmed/17325160" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17325160</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.keller.2011.5049">Keller KE, Bradley JM, Vranka JA, Acott TS. Segmental versican expression in the trabecular meshwork and involvement in outflow facility. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2011;<span class="ref-vol">52</span>:5049–57.</span> [<a href="/pmc/articles/PMC3176074/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3176074</span></a>] [<a href="/pubmed/21596823" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21596823</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.keren.2007.1514">Keren B, Suzuki OT, G&#x000e9;rard-Blanluet M, Br&#x000e9;mond-Gignac D, Elmaleh M, Titomanlio L, Delezoide AL, Passos-Bueno MR, Verloes A. CNS malformations in Knobloch syndrome with splice mutation in COL18A1 gene. <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:1514–8.</span> [<a href="/pubmed/17546652" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17546652</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.kloeckenergruissem.2006.350">Kloeckener-Gruissem B, Bartholdi D, Abdou MT, Zimmermann DR, Berger W. Identification of the genetic defect in the original Wagner syndrome family. <span><span class="ref-journal">Mol Vis. </span>2006;<span class="ref-vol">12</span>:350–5.</span> [<a href="/pubmed/16636652" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16636652</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.kloeckenergruissem.2013.352">Kloeckener-Gruissem B, Neidhardt J, Magyar I, Plauchu H, Zech JC, Morl&#x000e9; L, Palmer-Smith SM, Macdonald MJ, Nas V, Fry AE, Berger W. Novel VCAN mutations and evidence for unbalanced alternative splicing in the pathogenesis of Wagner syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2013;<span class="ref-vol">21</span>:352–6.</span> [<a href="/pmc/articles/PMC3573191/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3573191</span></a>] [<a href="/pubmed/22739342" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22739342</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.lemire.1999.1630">Lemire JM, Braun KR, Maurel P, Kaplan ED, Schwartz SM, Wight TN. Versican/PG-M isoforms in vascular smooth muscle cells. <span><span class="ref-journal">Arterioscler Thromb Vasc Biol. </span>1999;<span class="ref-vol">19</span>:1630–9.</span> [<a href="/pubmed/10397680" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10397680</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.mahajan.2012.e1003001">Mahajan VB, Skeie JM, Bassuk AG, Fingert JH, Braun TA, Daggett HT, Folk JC, Sheffield VC, Stone EM. Calpain-5 mutations cause autoimmune uveitis, retinal neovascularization, and photoreceptor degeneration. <span><span class="ref-journal">PLoS Genet. </span>2012;<span class="ref-vol">8</span>:e1003001.</span> [<a href="/pmc/articles/PMC3464205/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3464205</span></a>] [<a href="/pubmed/23055945" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23055945</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.menzel.2004.77">Menzel O, Bekkeheien RC, Reymond A, Fukai N, Boye E, Kosztolanyi G, Aftimos S, Deutsch S, Scott HS, Olsen BR, Antonarakis SE, Guipponi M. Knobloch syndrome: novel mutations in COL18A1, evidence for genetic heterogeneity, and a functionally impaired polymorphism in endostatin. <span><span class="ref-journal">Hum Mutat. </span>2004;<span class="ref-vol">23</span>:77–84.</span> [<a href="/pubmed/14695535" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14695535</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.meredith.2007.655">Meredith SP, Richards AJ, Flanagan DW, Scott JD, Poulson AV, Snead MP. Clinical characterisation and molecular analysis of Wagner syndrome. <span><span class="ref-journal">Br J Ophthalmol. </span>2007;<span class="ref-vol">91</span>:655–9.</span> [<a href="/pmc/articles/PMC1954774/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1954774</span></a>] [<a href="/pubmed/17035272" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17035272</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.miyamoto.2005.2726">Miyamoto T, Inoue H, Sakamoto Y, Kudo E, Naito T, Mikawa T, Mikawa Y, Isashiki Y, Osabe D, Shinohara S, Shiota H, Itakura M. Identification of a novel splice site mutation of the CSPG2 gene in a Japanese family with Wagner syndrome. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2005;<span class="ref-vol">46</span>:2726–35.</span> [<a href="/pubmed/16043844" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16043844</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay A, Nikopoulos K, Maugeri A, de Brouwer AP, van Nouhuys CE, Boon CJ, Perveen R, Zegers HA, Wittebol-Post D, van den Biesen PR, van der Velde-Visser SD, Brunner HG, Black GC, Hoyng CB, Cremers FP. Erosive vitreoretinopathy and wagner disease are caused by intronic mutations in CSPG2/Versican that result in an imbalance of splice variants. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2006;<span class="ref-vol">47</span>:3565–72.</span> [<a href="/pubmed/16877430" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16877430</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.oh.2006.940">Oh KT, Vallar C. Central cone dysfunction in autosomal dominant vitreoretino choroidopathy (ADVIRC). <span><span class="ref-journal">Am J Ophthalmol. </span>2006;<span class="ref-vol">141</span>:940–3.</span> [<a href="/pubmed/16678511" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16678511</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.ronan.2009.1511">Ronan SM, Tran-Viet KN, Burner EL, Metlapally R, Toth CA, Young TL. Mutational hot spot potential of a novel base pair mutation of the CSPG2 gene in a family with Wagner syndrome. <span><span class="ref-journal">Arch Ophthalmol. </span>2009;<span class="ref-vol">127</span>:1511–9.</span> [<a href="/pmc/articles/PMC3514888/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3514888</span></a>] [<a href="/pubmed/19901218" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19901218</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.rothschild.2013a.805">Rothschild PR, Audo I, Nedelec B, Ghiotti T, Br&#x000e9;zin AP, Monin C, Valleix S. De novo splice mutation in the versican gene in a family with Wagner syndrome. <span><span class="ref-journal">JAMA Ophthalmol. </span>2013a;<span class="ref-vol">131</span>:805–7.</span> [<a href="/pubmed/23571384" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23571384</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.rothschild.2013b.2040">Rothschild PR, Br&#x000e9;zin AP, Nedelec B, Burin des Roziers C, Ghiotti T, Orhant L, Boimard M, Valleix S. A family with Wagner syndrome with uveitis and a new versican mutation. <span><span class="ref-journal">Mol Vis. </span>2013b;<span class="ref-vol">19</span>:2040–9.</span> [<a href="/pmc/articles/PMC3811992/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3811992</span></a>] [<a href="/pubmed/24174867" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24174867</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.rothschild.2011.1555">Rothschild PR, L&#x000e9;vy D, Savignoni A, Lumbroso-Le Rouic L, Aerts I, Gauthier-Villars M, Esteve M, Bours D, Desjardins L, Doz F, L&#x000e9;vy-Gabriel C. Familial retinoblastoma: fundus screening schedule impact and guideline proposal. A retrospective study. <span><span class="ref-journal">Eye (Lond). </span>2011;<span class="ref-vol">25</span>:1555–61.</span> [<a href="/pmc/articles/PMC3234459/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3234459</span></a>] [<a href="/pubmed/21921957" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21921957</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.wagner.1938.840">Wagner H. Ein bisher unbekanntes Erbleiden des Auges, beobachtet im Kanton Zurich 1. <span><span class="ref-journal">Klinische Monatsbl&#x000e4;tter f&#x000fc;r Augenheilkunde. </span>1938;<span class="ref-vol">100</span>:840–57.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.wight.2014.152">Wight TN, Kang I, Merrilees MJ. Versican and the control of inflammation. <span><span class="ref-journal">Matrix Biol. </span>2014;<span class="ref-vol">35</span>:152–61.</span> [<a href="/pmc/articles/PMC4039577/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4039577</span></a>] [<a href="/pubmed/24513039" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24513039</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.white.2000.130">White TW, Bruzzone R. Intercellular communication in the eye: clarifying the need for connexin diversity. <span><span class="ref-journal">Brain Res Brain Res Rev. </span>2000;<span class="ref-vol">32</span>:130–7.</span> [<a href="/pubmed/10751662" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10751662</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.yao.1994.213">Yao LY, Moody C, Sch&#x000f6;nherr E, Wight TN, Sandell LJ. Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry. <span><span class="ref-journal">Matrix Biol. </span>1994;<span class="ref-vol">14</span>:213–25.</span> [<a href="/pubmed/7921538" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7921538</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="wagner.REF.zech.1999.387">Zech JC, Morl&#x000e9; L, Vincent P, Alloisio N, Bozon M, Gonnet C, Milazzo S, Grange JD, Trepsat C, Godet J, Plauchu H. Wagner vitreoretinal degeneration with genetic linkage refinement on chromosome 5q13-q14. <span><span class="ref-journal">Graefes Arch Clin Exp Ophthalmol. </span>1999;<span class="ref-vol">237</span>:387–93.</span> [<a href="/pubmed/10333105" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10333105</span></a>]</div></li></ul></div></div><div id="wagner.Chapter_Notes"><h2 id="_wagner_Chapter_Notes_">Chapter Notes</h2><div id="wagner.Acknowledgments"><h3>Acknowledgments</h3><p>The authors would like to thank Drs Wolfgang Berger and John Neidhardt for critical reading of the manuscript.</p></div><div id="wagner.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>7 January 2016 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>16 August 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>3 February 2009 (me) Review posted live</div></li><li class="half_rhythm"><div>18 April 2008 (bkg) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK3821</span><span class="label">PMID: <a href="/pubmed/20301747" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301747</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/usher2/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/vldlr-ch/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK3821&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK3821/?report=reader">PubReader</a></li><li><a href="/books/NBK3821/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK3821" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK3821" style="display:none" title="Cite this Page"><div class="bk_tt">Kloeckener-Gruissem B, Amstutz C. VCAN-Related Vitreoretinopathy. 2009 Feb 3 [Updated 2016 Jan 7]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK3821/pdf/Bookshelf_NBK3821.pdf">PDF version of this page</a> (217K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#wagner.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#wagner.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#wagner.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#wagner.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#wagner.Genetically_Related_Allelic_Disor" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#wagner.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#wagner.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#wagner.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#wagner.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#wagner.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#wagner.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#wagner.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1462[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">VCAN</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK3821+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1488466" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1488466" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1488466" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1488466" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29071374" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">WAGNER syndrome: anatomic, functional and genetic characterization of a Portuguese family.</a><span class="source">[Graefes Arch Clin Exp Ophthalm...]</span><div class="brieflinkpop offscreen_noflow">WAGNER syndrome: anatomic, functional and genetic characterization of a Portuguese family.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Araújo JR, Tavares-Ferreira J, Estrela-Silva S, Rocha P, Brandão E, Faria PA, Falcão-Reis F, Rocha-Sousa A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Graefes Arch Clin Exp Ophthalmol. 2018 Jan; 256(1):163-171. Epub 2017 Oct 25.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301510" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dietz H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21738396" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A new VCAN/versican splice acceptor site mutation in a French Wagner family associated with vascular and inflammatory ocular features.</a><span class="source">[Mol Vis. 2011]</span><div class="brieflinkpop offscreen_noflow">A new VCAN/versican splice acceptor site mutation in a French Wagner family associated with vascular and inflammatory ocular features.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brézin AP, Nedelec B, Barjol A, Rothschild PR, Delpech M, Valleix S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Mol Vis. 2011; 17:1669-78. Epub 2011 Jun 22.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30055036" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Is exon 8 the most critical or the only dispensable exon of the VCAN gene? Insights into VCAN variants and clinical spectrum of Wagner syndrome.</a><span class="source">[Am J Med Genet A. 2018]</span><div class="brieflinkpop offscreen_noflow">Is exon 8 the most critical or the only dispensable exon of the VCAN gene? Insights into VCAN variants and clinical spectrum of Wagner syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ankala A, Jain N, Hubbard B, Alexander JJ, Shankar SP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2018 Aug; 176(8):1778-1783. Epub 2018 Jul 28.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301326" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Familial Exudative Vitreoretinopathy, Autosomal Dominant</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Familial Exudative Vitreoretinopathy, Autosomal Dominant<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Toomes C, Downey L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301747" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301747" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0410dddde089116991d9e2">VCAN-Related Vitreoretinopathy - GeneReviews®</a><div class="ralinkpop offscreen_noflow">VCAN-Related Vitreoretinopathy - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:46:06-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE89A5C7E04028D10000000006B202EB&amp;ncbi_session=CE89A5C7E0410DD1_1714SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK3821%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK3821&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK3821/&amp;ncbi_pagename=VCAN-Related Vitreoretinopathy - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE89A5C7E0410DD1_1714SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>